September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Growth hormone-releasing hormone (GHRH) antagonist induces apoptosis in retinoblastoma
Author Affiliations & Notes
  • WAI KIT CHU
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Fuk Loi Benjamin Li
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Ka Sin Law
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • SUNON CHAN
    School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Herman S Cheung
    Department of Biomedical Engineering, University of Miami, Miami, Florida, United States
  • Andrew V Schally
    Endocrine, Polypeptide and Cancer Institute, University of Miami, Miami, Florida, United States
  • Chi Pui Calvin Pang
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Footnotes
    Commercial Relationships   WAI KIT CHU, None; Fuk Loi Benjamin Li, None; Ka Sin Law, None; SUNON CHAN, None; Herman S Cheung, None; Andrew V Schally, None; Chi Pui Pang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3661. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      WAI KIT CHU, Fuk Loi Benjamin Li, Ka Sin Law, SUNON CHAN, Herman S Cheung, Andrew V Schally, Chi Pui Calvin Pang; Growth hormone-releasing hormone (GHRH) antagonist induces apoptosis in retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3661.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Growth hormone-releasing hormone (GHRH) and its receptor (GHRHR) have been shown to correlate with proliferation and survival of several reported malignancies. In this study we investigated an extra-pituitary role of GHRHR in retinoblastoma (RB), with further exploration of novel GHRHR antagonists and agonist in inducing apoptosis in retinoblastoma cells.

Methods : Expression pattern of GHRHR in Y79 retinoblastoma was thoroughly characterized in terms of immunoblot determination, subcellular localization as well as populational distribution. GHRHR expressions in normal retinal cell lines of ARPE19 retinal pigmented epithelium and SVG neuroglia were compared with Y79. Effects of GHRH antagonist MIA602, MIA690 and agonist MR409 on Y79 were evaluated with respect to apoptosis induction.

Results : GHRHR were shown qualitatively and quantitatively overexpressing in Y79 retinoblastoma in comparison to ARPE19 and SVG. GHRHR-expressing cells contributed to the whole population of Y79, with subcellular localization featured as cytoplasmic and/or cell surface expression. GHRHR antagonists MIA-602 and MIA-690 demonstrated pro-apoptotic effects, while GHRHR agonist MR-409 did not show any effect in inducing apoptosis. MIA-602 regulated gene signaling in relation to proliferation and apoptosis such as upregulating gene expression of Caspase 3 and downregulating gene expression of ERK1 and ERK2.

Conclusions : Differential GHRHR overexpression of retinoblastoma in retina has implied its susceptibility as a selective molecular target for anti-cancer therapy. This study has further indicated GHRHR blockage can be a potential strategy against retinoblastoma via induction of apoptosis.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×